Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
doi: 10.2147/OAJU.S22916 170 Soler FernndezJMCaravaca MagariosFDomnguez BravoCMurillo MiratJAparicio PalominoAHerrera PuertoJ
Multiple in vivo and in vitro studies have examined candidate stem cell sources for oral disease treatment, among which DPSCs are considered particularly promising due to their superior proliferative ability and enhanced resistance to subculture-induced and inflammation-induced senescence
10.1016/j.cell.2017.11.048 Cell 89 ItohM.SuzukiK
l- ,
study found that 11.9% of patients experienced worsening, 0.4% saw resolution, and 0.8% stabilized during the study period, the relatively short follow-up means many participants were still in the active shedding phase when assessed
Thai Forest Bulletin (Botany) 50:2039
US$ 23.65
US$ 20.80
US$ 24.73
US$ 28.80
US$ 20.02
